Citigroup
STLN icon

Citigroup’s Starling Oncology STLN Stock Holding History

Citigroup’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$23.9K Sell
3,780
-31,967
-89% -$191K ﹤0.01% 4934
2026
Q2 		$194K Buy
35,747
+31,565
+755% +$133K ﹤0.01% 4359
2026
Q1 		$12.8K Buy
4,182
+2,431
+139% +$7.45K ﹤0.01% 4951
2025
Q4 		$6.23K Sell
1,751
-799
-31% -$2.96K ﹤0.01% 5183
2025
Q3 		$8.9K Sell
2,550
-18,410
-88% -$63.1K ﹤0.01% 5060
2025
Q2 		$43K Buy
20,960
+20,957
+698,567% +$52.4K ﹤0.01% 4847
2025
Q1 		$3 Sell
3
-631
-100% -$489 ﹤0.01% 5513
2024
Q4 		$196 Buy
634
+609
+2,436% +$158 ﹤0.01% 5666
2024
Q3 		$8 Sell
25
-15
-38% -$6 ﹤0.01% 5628
2024
Q2 		$18 Sell
40
-12,814
-100% -$10.9K ﹤0.01% 5497
2024
Q1 		$20.3K Buy
12,854
+12,356
+2,481% +$23.5K ﹤0.01% 5027
2023
Q4 		$1.02K Hold
498
– – ﹤0.01% 5465
2023
Q3 		$697 Hold
498
– – ﹤0.01% 5157
2023
Q2 		$274 Buy
+498
New +$263 ﹤0.01% 5415
2023
Q1 		– Sell
-235
Closed -$388 – 5860
2022
Q4 		$388 Sell
235
-294
-56% -$825 ﹤0.01% 5537
2022
Q3 		$2K Sell
529
-608
-53% -$3.58K ﹤0.01% 5537
2022
Q2 		$6K Buy
+1,137
New +$8.28K ﹤0.01% 5569

Other funds holding STLN

Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Kingswood Wealth Advisors
Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Berkshire Money Management
Berkshire Money Management Dalton, Massachusetts $1.16B AUM 13.8% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Pekin Hardy Strauss
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 25.53% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

Citigroup's STLN Position: Q3 2026 in Review

Citigroup reduced its Starling Oncology (STLN) stake by 89% in Q3 2026, selling an estimated $191K and leaving 3,780 shares worth $23.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4934.

Citigroup first reported a position in STLN in Q2 2022 and has held it in 17 quarters since. The position peaked at $194K in Q2 2026. 25 funds tracked by Wall St. Rank hold STLN as of Q3 2026.

  • Citigroup held 3,780 shares of Starling Oncology worth $23.9K as of Q3 2026.
  • Citigroup sold 31,967 Starling Oncology shares in Q3 2026, an estimated $191K.
  • Starling Oncology made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #4934 holding.
  • Citigroup first reported a position in Starling Oncology in Q2 2022 and has held it in 17 quarters since.
  • Citigroup's Starling Oncology position peaked at $194K in Q2 2026.
  • 25 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.